Isoflurane structure
|
Common Name | Isoflurane | ||
|---|---|---|---|---|
| CAS Number | 26675-46-7 | Molecular Weight | 184.492 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 48.5±0.0 °C at 760 mmHg | |
| Molecular Formula | C3H2ClF5O | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | -10.6±25.9 °C | |
| Symbol |
GHS07, GHS08 |
Signal Word | Warning | |
| Name | isoflurane |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 48.5±0.0 °C at 760 mmHg |
| Molecular Formula | C3H2ClF5O |
| Molecular Weight | 184.492 |
| Flash Point | -10.6±25.9 °C |
| Exact Mass | 183.971436 |
| PSA | 9.23000 |
| LogP | 2.33 |
| Vapour Pressure | 323.0±0.0 mmHg at 25°C |
| Index of Refraction | 1.301 |
| InChIKey | PIWKPBJCKXDKJR-UHFFFAOYSA-N |
| SMILES | FC(F)OC(Cl)C(F)(F)F |
| Stability | Stable. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H336-H373 |
| Precautionary Statements | P260 |
| Target Organs | Cardio-vascular system, Central nervous system |
| Hazard Codes | F,T |
| Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . |
| Safety Phrases | S26-S36/37/39 |
| RIDADR | UN 3334 |
| RTECS | KN6799000 |
| HS Code | 3004909030 |
|
~96%
Isoflurane CAS#:26675-46-7 |
| Literature: Journal of Fluorine Chemistry, , vol. 80, # 2 p. 101 - 104 |
|
~%
Isoflurane CAS#:26675-46-7 |
| Literature: Journal of medicinal chemistry, , vol. 15, # 6 p. 604 - 606 |
|
~%
Isoflurane CAS#:26675-46-7 |
| Literature: Journal of medicinal chemistry, , vol. 14, # 6 p. 517 - 519 |
| HS Code | 2909199090 |
|---|---|
| Summary | 2909199090. other acyclic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
|
Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited.
Stroke 46(3) , 835-42, (2015) Ischemic stroke has been shown to cause hypermetabolism of glucose in the ischemic penumbra. Experimental and clinical data indicate that infarct-related systemic hyperglycemia is a potential therapeu... |
|
|
Suppression of the HSF1-mediated proteotoxic stress response by the metabolic stress sensor AMPK.
EMBO J. 34(3) , 275-93, (2015) Numerous extrinsic and intrinsic insults trigger the HSF1-mediated proteotoxic stress response (PSR), an ancient transcriptional program that is essential to proteostasis and survival under such condi... |
|
|
Detailed characterization of a long-term rodent model of critical illness and recovery.
Crit. Care Med. 43(3) , e84-96, (2015) To characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.Randomized controlled animal study.University researc... |
| 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane |
| Isoflurano |
| 1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether |
| Forane |
| Compd 469 |
| Isoflurane |
| 1-Chlor-2,2,2-trifluorethyl-difluormethylether |
| 2-(difluoromethoxy)-1,1,1-trifluoro-2-chloroethane |
| 2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane |
| MFCD00066609 |
| Forene |
| EINECS 247-897-7 |
| Isofluranum |
| Compound 469 |
| IsoFlo |
| Aerrane |